Sign in or create an account to add this stock to your watchlist.
About Agilent Technologies (NYSE:A)
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:A
CUSIP00846U10
Phone408-345-8886
Debt
Debt-to-Equity Ratio0.39
Current Ratio3.32
Quick Ratio2.88
Price-To-Earnings
Trailing P/E Ratio26.76
Forward P/E Ratio23.65
P/E Growth2.24
Sales & Book Value
Annual Sales$4.47 billion
Price / Sales4.55
Cash Flow$2.9986 per share
Price / Cash21.06
Book Value$14.32 per share
Price / Book4.41
Profitability
EPS (Most Recent Fiscal Year)$2.36
Net Income$684 million
Net Margins5.02%
Return on Equity18.01%
Return on Assets9.80%
Miscellaneous
Employees13,500
Outstanding Shares322,480,000
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies declared a quarterly dividend on Wednesday, May 16th. Investors of record on Tuesday, July 3rd will be given a dividend of $0.149 per share on Wednesday, July 25th. This represents a $0.60 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend is Monday, July 2nd. View Agilent Technologies' Dividend History.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies Inc (NYSE:A) released its earnings results on Monday, May, 14th. The medical research company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.01. The medical research company earned $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The business's revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.58 EPS. View Agilent Technologies' Earnings History.
When is Agilent Technologies' next earnings date?
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies issued an update on its FY18 earnings guidance on Monday, May, 14th. The company provided earnings per share (EPS) guidance of $2.63-2.67 for the period, compared to the Thomson Reuters consensus estimate of $2.70. The company issued revenue guidance of $4.85-4.87 billion, compared to the consensus revenue estimate of $4.92 billion.Agilent Technologies also updated its Q3 guidance to $0.61-0.63 EPS.
What price target have analysts set for A?
12 equities research analysts have issued 1-year price objectives for Agilent Technologies' shares. Their predictions range from $60.73 to $91.00. On average, they expect Agilent Technologies' share price to reach $72.8108 in the next year. View Analyst Ratings for Agilent Technologies.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Pacific Biosciences of California (PACB), Fluidigm (FLDM) and Harvard Bioscience (HBIO).
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 57)
- Mr. Didier Hirsch, Sr. VP & CFO (Age 67)
- Mr. Mark Doak, Sr. VP & Pres of Agilent CrossLab Group (Age 63)
- Mr. Patrick K. Kaltenbach, Sr. VP and Pres of Life Sciences & Applied Markets Group (LSAG) Bus. Unit (Age 55)
- Mr. Jacob Thaysen, Sr. VP and Pres of Diagnostics & Genomics Group (Age 43)
Has Agilent Technologies been receiving favorable news coverage?
Media coverage about A stock has been trending somewhat positive this week, according to Accern. Accern scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Agilent Technologies earned a news impact score of 0.05 on Accern's scale. They also gave media coverage about the medical research company an impact score of 47.17 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
Who are Agilent Technologies' major shareholders?
Agilent Technologies' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.82%), OppenheimerFunds Inc. (1.44%), JPMorgan Chase & Co. (1.24%), Cantillon Capital Management LLC (1.20%), Northern Trust Corp (1.19%) and American Century Companies Inc. (1.09%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.
Which major investors are selling Agilent Technologies stock?
A stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Victory Capital Management Inc., Cantillon Capital Management LLC, PNC Financial Services Group Inc., State of Tennessee Treasury Department, Select Equity Group L.P., Swiss National Bank and Sei Investments Co.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.
Which major investors are buying Agilent Technologies stock?
A stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., OppenheimerFunds Inc., Old Mutual Global Investors UK Ltd., Royal Bank of Canada, Echo Street Capital Management LLC, Wells Fargo & Company MN, Natixis and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Agilent Technologies.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $63.15.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $20.68 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
Agilent Technologies (NYSE:A) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
12 Wall Street analysts have issued ratings and price targets for Agilent Technologies in the last 12 months. Their average twelve-month price target is $72.8108, suggesting that the stock has a possible upside of 15.30%. The high price target for A is $91.00 and the low price target for A is $60.73. There are currently 1 hold rating and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.92 | 2.85 | 2.77 | 2.69 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $72.8108 | $72.21 | $70.5946 | $67.7485 |
| Price Target Upside: | 15.30% upside | 8.36% upside | 1.69% downside | 1.37% downside |
Agilent Technologies (NYSE:A) Consensus Price Target History
Agilent Technologies (NYSE:A) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
Agilent Technologies (NYSE:A) Dividend Information
Agilent Technologies pays an annual dividend of $0.60 per share, with a dividend yield of 0.95%. A's next quarterly dividend payment will be made on Wednesday, July 25. Agilent Technologies pays out 25.42% of its earnings out as a dividend.
| Next Dividend: | 7/25/2018 |
| Annual Dividend: | $0.60 |
| Dividend Yield: | 0.95% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio(s): | 25.42% (Trailing 12 Months of Earnings)
22.47% (Based on This Year's Estimates)
20.41% (Based on Next Year's Estimates)
20.01% (Based on Cash Flow)
|
| Track Record: | 2 Years of Consecutive Dividend Growth |
| Frequency: | Quarterly Dividend |
Agilent Technologies (NYSE:A) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/16/2018 | quarterly | $0.1490 | 0.96% | 7/2/2018 | 7/3/2018 | 7/25/2018 |
| 3/21/2018 | quarterly | $0.1490 | 0.89% | 4/2/2018 | 4/3/2018 | 4/25/2018 |
| 11/15/2017 | quarterly | $0.1490 | 0.87% | 12/29/2017 | 1/2/2018 | 1/24/2018 |
| 9/20/2017 | quarterly | $0.1320 | 0.8% | 10/2/2017 | 10/3/2017 | 10/25/2017 |
| 5/17/2017 | quarterly | $0.1320 | 0.95% | 6/29/2017 | 7/3/2017 | 7/26/2017 |
| 3/15/2017 | quarterly | $0.1320 | 1% | 3/31/2017 | 4/4/2017 | 4/26/2017 |
| 11/17/2016 | quarterly | $0.1320 | 1.17% | 12/29/2016 | 1/3/2017 | 1/25/2017 |
| 9/21/2016 | quarterly | $0.1150 | 0.99% | 9/30/2016 | 10/4/2016 | 10/26/2016 |
| 5/18/2016 | quarterly | $0.1150 | 1.03% | 6/30/2016 | 7/5/2016 | 7/27/2016 |
| 3/16/2016 | quarterly | $0.1150 | 1.17% | 4/1/2016 | 4/5/2016 | 4/27/2016 |
| 11/19/2015 | quarterly | $0.1150 | 1.17% | 12/31/2015 | 1/5/2016 | 1/27/2016 |
| 9/16/2015 | quarterly | $0.10 | 1.1% | 9/25/2015 | 9/29/2015 | 10/21/2015 |
| 5/20/2015 | quarterly | $0.10 | 0.95% | 6/26/2015 | 6/30/2015 | 7/22/2015 |
| 3/18/2015 | quarterly | $0.10 | 0.95% | 3/27/2015 | 3/31/2015 | 4/22/2015 |
| 11/20/2014 | quarterly | $0.10 | 0.95% | 1/2/2015 | 1/6/2015 | 1/28/2015 |
| 9/17/2014 | quarterly | $0.1320 | 0.9% | 9/26/2014 | 9/30/2014 | 10/22/2014 |
| 5/22/2014 | quarterly | $0.1320 | 0.94% | 6/27/2014 | 7/1/2014 | 7/23/2014 |
| 4/1/2014 | quarterly | $0.13 | 0.93% | 4/9/2014 | 4/11/2014 | 4/23/2014 |
| 11/22/2013 | quarterly | $0.1320 | 0.99% | 12/27/2013 | 12/31/2013 | 1/22/2014 |
| 9/18/2013 | quarterly | $0.12 | 0.94% | 9/27/2013 | 10/1/2013 | 10/23/2013 |
| 5/23/2013 | quarterly | $0.12 | 1.05% | 6/28/2013 | 7/2/2013 | 7/24/2013 |
| 1/17/2013 | quarterly | $0.12 | 1.09% | 3/28/2013 | 4/2/2013 | 4/24/2013 |
(Data available from 1/1/2013 forward)
Agilent Technologies (NYSE A) Insider Trading and Institutional Ownership History
Agilent Technologies (NYSE A) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/29/2018 | Patrick Kaltenbach | Insider | Sell | 4,000 | $67.28 | $269,120.00 | 72,547 |  |
| 3/27/2018 | Heidi Fields | Director | Sell | 5,000 | $68.09 | $340,450.00 | 57,563 | |
| 3/13/2018 | Rodney Gonsalves | VP | Sell | 6,825 | $71.23 | $486,144.75 | | |
| 3/12/2018 | Patrick Kaltenbach | Insider | Sell | 6,875 | $71.38 | $490,737.50 | | |
| 1/29/2018 | Michael R Mcmullen | CEO | Sell | 21,850 | $75.00 | $1,638,750.00 | 324,687 | |
| 1/18/2018 | Michael R Mcmullen | CEO | Sell | 21,850 | $72.50 | $1,584,125.00 | 324,687 | |
| 1/5/2018 | Michael R Mcmullen | CEO | Sell | 43,703 | $70.00 | $3,059,210.00 | 302,837 | |
| 12/18/2017 | Mark Doak | Insider | Sell | 15,567 | $68.00 | $1,058,556.00 | 71,104 | |
| 12/5/2017 | Mark Doak | VP | Sell | 4,154 | $67.00 | $278,318.00 | 68,270 | |
| 11/28/2017 | Jacob Thaysen | SVP | Sell | 22,583 | $70.41 | $1,590,069.03 | 63,042 | |
| 11/28/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $69.56 | $347,800.00 | 75,504 | |
| 11/27/2017 | Didier Hirsch | CFO | Sell | 20,000 | $69.40 | $1,388,000.00 | 204,851 | |
| 11/22/2017 | Didier Hirsch | CFO | Sell | 12,964 | $69.00 | $894,516.00 | 184,851 | |
| 11/22/2017 | Patrick Kaltenbach | Insider | Sell | 7,358 | $69.28 | $509,762.24 | 72,862 | |
| 11/20/2017 | Michael R Mcmullen | CEO | Sell | 22,481 | $70.00 | $1,573,670.00 | 327,882 | |
| 11/17/2017 | Michael R Mcmullen | CEO | Sell | 22,481 | $68.77 | $1,546,018.37 | 336,637 | |
| 9/15/2017 | Didier Hirsch | CFO | Sell | 15,555 | $66.00 | $1,026,630.00 | 178,557 | |
| 9/14/2017 | Michael R Mcmullen | CEO | Sell | 16,492 | $65.33 | $1,077,422.36 | 211,872 | |
| 9/13/2017 | Didier Hirsch | CFO | Sell | 1,200 | $66.00 | $79,200.00 | 164,202 | |
| 9/8/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $65.26 | $326,300.00 | 45,143 | |
| 8/31/2017 | Didier Hirsch | CFO | Sell | 20,000 | $64.00 | $1,280,000.00 | 183,002 | |
| 8/30/2017 | Boon Hwee Koh | Director | Sell | 4,500 | $63.63 | $286,335.00 | | |
| 8/23/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $63.26 | $316,300.00 | | |
| 8/22/2017 | Didier Hirsch | CFO | Sell | 72,545 | $62.38 | $4,525,357.10 | | |
| 8/18/2017 | Mark Doak | Insider | Sell | 12,421 | $61.57 | $764,760.97 | | |
| 8/16/2017 | Dominique Grau | Insider | Sell | 13,007 | $62.00 | $806,434.00 | 60,098 | |
| 7/13/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $61.26 | $306,300.00 | 45,138 | |
| 6/16/2017 | Heidi Fields | Director | Sell | 8,625 | $59.53 | $513,446.25 | | |
| 6/1/2017 | Didier Hirsch | CFO | Sell | 5,710 | $60.60 | $346,026.00 | | |
| 5/31/2017 | Patrick Kaltenbach | Insider | Sell | 2,074 | $60.43 | $125,331.82 | 42,212 | |
| 5/30/2017 | Mark Doak | Insider | Sell | 21,851 | $60.00 | $1,311,060.00 | | |
| 5/25/2017 | Paul N. Clark | Director | Sell | 3,866 | $59.05 | $228,287.30 | | |
| 5/24/2017 | James Cullen | Director | Sell | 15,482 | $59.04 | $914,057.28 | | |
| 5/23/2017 | Michael R. Mcmullen | CEO | Sell | 50,000 | $59.86 | $2,993,000.00 | | |
| 5/4/2017 | Patrick Kaltenbach | Insider | Sell | 5,000 | $56.50 | $282,500.00 | | |
| 5/1/2017 | Michael R Mcmullen | CEO | Sell | 32,511 | $55.48 | $1,803,710.28 | 260,346 | |
| 4/24/2017 | Patrick Kaltenbach | Insider | Sell | 2,000 | $54.50 | $109,000.00 | 42,132 | |
| 4/10/2017 | Patrick Kaltenbach | Insider | Sell | 2,000 | $52.90 | $105,800.00 | 42,132 | |
| 3/27/2017 | Mark Doak | Insider | Sell | 3,607 | $53.14 | $191,675.98 | | |
| 3/10/2017 | Rodney Gonsalves | VP | Sell | 8,496 | $52.05 | $442,216.80 | | |
| 2/16/2017 | Patrick Kaltenbach | Insider | Sell | 3,771 | $51.68 | $194,885.28 | | |
| 2/15/2017 | Didier Hirsch | CFO | Sell | 22,258 | $51.50 | $1,146,287.00 | 190,285 | |
| 2/9/2017 | Didier Hirsch | CFO | Sell | 22,256 | $50.50 | $1,123,928.00 | 190,283 | |
| 2/1/2017 | Didier Hirsch | CFO | Sell | 22,256 | $49.50 | $1,101,672.00 | | |
| 1/9/2017 | Didier Hirsch | CFO | Sell | 22,256 | $48.50 | $1,079,416.00 | 190,023 | |
| 12/9/2016 | Mark Doak | Insider | Sell | 3,969 | $46.00 | $182,574.00 | 54,626 | |
| 11/18/2016 | Paul N. Clark | Director | Sell | 4,704 | $45.31 | $213,138.24 | | |
| 9/30/2016 | Patrick Kaltenbach | Insider | Sell | 2,000 | $47.30 | $94,600.00 | 22,463 | |
| 9/6/2016 | Heidi Fields | Director | Sell | 8,072 | $46.99 | $379,303.28 | 51,836 | |
| 8/31/2016 | Patrick Kaltenbach | Insider | Sell | 2,000 | $47.00 | $94,000.00 | 22,463 | |
| 8/29/2016 | Rodney Gonsalves | VP | Sell | 8,141 | $47.82 | $389,302.62 | 16,322 | |
| 8/24/2016 | Boon Hwee Koh | Director | Sell | 5,298 | $47.66 | $252,502.68 | | |
| 8/22/2016 | James Cullen | Director | Sell | 13,574 | $47.52 | $645,036.48 | | |
| 5/27/2016 | James Cullen | Director | Sell | 16,697 | $45.78 | $764,388.66 | 92,613 | |
| 5/23/2016 | James Cullen | Director | Sell | 16,922 | $44.63 | $755,228.86 | 84,541 | |
| 5/19/2016 | Mark Doak | VP | Sell | 18,879 | $44.14 | $833,319.06 | 30,827 | |
| 5/19/2016 | Michael R Mcmullen | CEO | Sell | 124,411 | $44.46 | $5,531,313.06 | 171,473 | |
| 5/19/2016 | Patrick Kaltenbach | SVP | Sell | 5,266 | $44.07 | $232,072.62 | 25,729 | |
| 5/18/2016 | Rodney Gonsalves | VP | Sell | 9,542 | $44.24 | $422,138.08 | 16,322 | |
| 5/11/2016 | Dominique Grau | SVP | Sell | 10,322 | $43.00 | $443,846.00 | 46,268 | |
| 4/14/2016 | Dominique Grau | SVP | Sell | 10,321 | $41.00 | $423,161.00 | 46,267 | |
| 3/31/2016 | Dominique Grau | SVP | Sell | 10,321 | $40.00 | $412,840.00 | 46,267 | |
| 3/31/2016 | Heidi Fields | Director | Sell | 30,000 | $39.91 | $1,197,300.00 | 57,312 | |
| 3/18/2016 | Robert J Herbold | Director | Sell | 8,072 | $40.30 | $325,301.60 | | |
| 6/29/2015 | Boon Hwee Koh | Director | Sell | 5,000 | $39.61 | $198,050.00 | | |
| 6/26/2015 | Mark Doak | VP | Sell | 7,938 | $40.01 | $317,599.38 | | |
| 6/25/2015 | Robert J Herbold | Director | Sell | 8,870 | $40.00 | $354,800.00 | | |
| 4/14/2015 | Michael R Mcmullen | CEO | Sell | 43,130 | $42.72 | $1,842,513.60 | | |
| 3/10/2015 | A Barry Rand | Director | Sell | 8,870 | $40.95 | $363,226.50 | | |
| 3/4/2015 | Paul N Clark | Director | Sell | 37,973 | $41.87 | $1,589,929.51 | | |
| 3/3/2015 | Patrick Kaltenbach | SVP | Sell | 1,149 | $42.41 | $48,729.09 | | |
| 3/2/2015 | Dominique Grau | SVP | Sell | 10,949 | $42.63 | $466,755.87 | | |
| 2/20/2015 | Solange Glaize | CAO | Sell | 32,700 | $41.78 | $1,366,206.00 | | |
| 12/1/2014 | William P Sullivan | CEO | Sell | 43,667 | $41.83 | $1,826,590.61 | | |
| 9/30/2014 | Heidi Fields | Director | Sell | 5,032 | $57.17 | $287,679.44 | | |
| 9/29/2014 | Didier Hirsch | CFO | Sell | 25,237 | $56.96 | $1,437,499.52 | | |
| 9/26/2014 | William P Sullivan | CEO | Sell | 494,887 | $56.45 | $27,936,371.15 | | |
| 9/19/2014 | Didier Hirsch | CFO | Sell | 24,051 | $58.48 | $1,406,502.48 | | |
| 6/23/2014 | Michael R Mcmullen | SVP | Sell | 35,377 | $58.56 | $2,071,677.12 | | |
| 6/17/2014 | Jean Halloran | SVP | Sell | 78,130 | $59.13 | $4,619,826.90 | | |
| 3/21/2014 | Marie Oh Huber | SVP | Sell | 60,567 | $56.60 | $3,428,092.20 | 32,582 | |
| 3/12/2014 | William Sullivan | CEO | Sell | 231,092 | $56.66 | $13,093,672.72 | 401,638 | |
| 2/21/2014 | Heidi Fields | Director | Sell | 3,464 | $56.80 | $196,755.20 | 51,620 | |
| 12/30/2013 | Michael Mcmullen | SVP | Sell | 4,402 | $57.39 | $252,630.78 | 76,213 | |
| 12/18/2013 | Didier Hirsch | CFO | Sell | 25,539 | $56.61 | $1,445,762.79 | 59,325 | |
| 12/6/2013 | Jean Halloran | SVP | Sell | 55,127 | $53.82 | $2,966,935.14 | 75,545 | |
| 11/20/2013 | Boon Hwee Koh | Director | Sell | 5,651 | $53.77 | $303,854.27 | 47,276 | |
| 9/23/2013 | Marie Oh Huber | SVP | Sell | 40,516 | $51.82 | $2,099,539.12 | 25,264 | |
| 9/20/2013 | Didier Hirsch | CFO | Sell | 17,327 | $52.00 | $901,004.00 | 54,412 | |
| 9/20/2013 | Ronald Nersesian | EVP | Sell | 181,480 | $51.92 | $9,422,441.60 | 46,339 | |
| 9/19/2013 | Michael Mcmullen | SVP | Sell | 10,000 | $52.48 | $524,800.00 | 91,102 | |
| 6/19/2013 | Michael R Mcmullen | SVP | Sell | 43,253 | $44.66 | $1,931,678.98 | | |
| 5/22/2013 | Didier Hirsch | CFO | Sell | 10,002 | $47.00 | $470,094.00 | | |
| 5/17/2013 | James Cullen | Director | Sell | 8,329 | $45.31 | $377,386.99 | | |
| 8/28/2012 | Heidi Fields | Director | Buy | 1,755 | $37.21 | $65,303.55 | | |
(Data available from 1/1/2013 forward)
Agilent Technologies (NYSE A) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Agilent's (A) Latest Buyout to Bolster Presence in Korea
www.msn.com - May 24 at 5:00 PM |
 | Agilent and University of Duisburg-Essen Announce Collaboration Agreement
finance.yahoo.com - May 24 at 5:00 PM |
 | $1.20 Billion in Sales Expected for Agilent Technologies Inc (A) This Quarter
www.americanbankingnews.com - May 24 at 4:36 AM |
 | Agilent Technologies (A) Reports Agreement to Acquire Assets from Young In Scientific Co. Ltd.
www.streetinsider.com - May 23 at 5:03 PM |
 | BRIEF-Agilent signs agreement to acquire assets from Young In Scientific
www.reuters.com - May 23 at 8:47 AM |
 | Agilent To Buy Assets From Young In Scientific; Terms Undisclosed
www.nasdaq.com - May 23 at 8:47 AM |
| Agilent Signs Agreement to Acquire Assets from Young In Scientific Co. Ltd.
finance.yahoo.com - May 23 at 8:47 AM |
| $0.63 Earnings Per Share Expected for Agilent Technologies (A) This Quarter
www.americanbankingnews.com - May 22 at 9:40 AM |
 | Global Endocrine Test Market Growth Opportunities: bioMerieux SA, Biomedical Technologies Inc.
www.marketwatch.com - May 22 at 8:51 AM |
| Analyzing Harvard Bioscience (HBIO) and Agilent Technologies (A)
www.americanbankingnews.com - May 17 at 9:17 PM |
| Agilent Technologies (A) Declares $0.149 Quarterly Dividend; 1% Yield
www.streetinsider.com - May 17 at 9:06 AM |
| Agilent Technologies and Three More Healthcare Stocks Under Our Scanner
finance.yahoo.com - May 17 at 9:06 AM |
| Leerink Swann Weighs in on Agilent Technologies' FY2018 Earnings (A)
www.americanbankingnews.com - May 17 at 7:34 AM |
| Agilent Technologies (A) Declares $0.15 Quarterly Dividend
www.americanbankingnews.com - May 16 at 6:19 PM |
| Agilent Technologies (A) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - May 16 at 11:04 AM |
| Edited Transcript of A earnings conference call or presentation 14-May-18 8:30pm GMT
finance.yahoo.com - May 16 at 9:07 AM |
| Agilent (A) Completes Genohm Buyout, Strengthens Portfolio
finance.yahoo.com - May 16 at 9:07 AM |
| Agilent Technologies: S&P 500’s Top Loss on May 15
finance.yahoo.com - May 16 at 9:07 AM |
| Q3 2018 EPS Estimates for Agilent Technologies Cut by Leerink Swann (A)
www.americanbankingnews.com - May 16 at 8:04 AM |
| Agilent Technologies (A) to Post Q3 2018 Earnings of $0.63 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - May 16 at 7:37 AM |
| Investors Purchase High Volume of Agilent Technologies Put Options (A)
www.americanbankingnews.com - May 16 at 6:46 AM |
| Why Switch, Vipshop Holdings, and Agilent Technologies Slumped Today
finance.yahoo.com - May 15 at 5:16 PM |
| Agilent Technologies (A) Upgraded by Cowen to "Outperform"
www.americanbankingnews.com - May 15 at 11:34 AM |
 | Agilent Technologies (A) CEO Michael McMullen on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 9:21 AM |
| Agilent Technologies Inc. 2018 Q2 - Results - Earnings Call Slides
seekingalpha.com - May 15 at 9:21 AM |
| BRIEF-Agilent Technologies Q2 GAAP Earnings Per Share $0.63
www.reuters.com - May 15 at 9:21 AM |
| Agilent (A) Reports In-Line Q2 Earnings, Misses on Revenues
finance.yahoo.com - May 15 at 9:21 AM |
| Agilent Technologies (A) Issues Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - May 15 at 8:44 AM |
| Agilent Technologies (A) Updates FY18 Earnings Guidance
www.americanbankingnews.com - May 14 at 5:12 PM |
| Agilent Technologies (A) Updates Q3 Earnings Guidance
www.americanbankingnews.com - May 14 at 5:12 PM |
 | Agilent Technologies Inc Stock Nosedives Despite 10% Revenue Growth
investorplace.com - May 14 at 4:57 PM |
| Agilent Maintains Bullish Post-Earnings Trading History for Longs
www.nasdaq.com - May 14 at 4:54 PM |
| Agilent Technologies Q2 adjusted earnings Beat Estimates
www.nasdaq.com - May 14 at 4:54 PM |
| Agilent FQ2 top line up 9%; earnings up 25%; cash flow up 18%; shares down 7% after hours
seekingalpha.com - May 14 at 4:54 PM |
| Agilent: Fiscal 2Q Earnings Snapshot
finance.yahoo.com - May 14 at 4:54 PM |
| Agilent Technologies Reports Second-Quarter Fiscal Year 2018 Financial Results
finance.yahoo.com - May 14 at 4:54 PM |
| Should You Buy Agilent Technologies Inc (NYSE:A) At $69.45?
finance.yahoo.com - May 14 at 4:54 PM |
| Agilent stock falls after earnings
finance.yahoo.com - May 14 at 4:54 PM |
| Agilent Technologies (A) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 14 at 11:29 AM |
| Financial Comparison: Agilent Technologies (A) vs. Precipio (PRPO)
www.americanbankingnews.com - May 14 at 11:05 AM |
| ZTE, Xerox, Tesla and NXP - 5 Things You Must Know
finance.yahoo.com - May 14 at 9:28 AM |
| Agilent Completes Acquisition of Genohm
finance.yahoo.com - May 14 at 9:28 AM |
| Agilent Technologies (A) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - May 14 at 1:20 AM |
| Agilent Technologies reports Q2 earnings May 14
www.nasdaq.com - May 12 at 9:22 AM |
| Will New Technologies Benefit Agilent (A) in Q2 Earnings?
finance.yahoo.com - May 11 at 5:05 PM |
| Agilent Completes Acquisition of Lasergen, Inc.
finance.yahoo.com - May 7 at 5:04 PM |
| Global Flow Cytometry Market Competitive landscape: Luminex Corporation, Agilent Technologies
www.marketwatch.com - May 7 at 8:52 AM |
| Global Gene Expression Analysis Market Competitive landscape: Agilent Technologies, QIAGEN N.V.
www.marketwatch.com - May 7 at 8:52 AM |
| $1.21 Billion in Sales Expected for Agilent Technologies (A) This Quarter
www.americanbankingnews.com - May 6 at 1:44 AM |
| Zacks: Analysts Anticipate Agilent Technologies (A) to Announce $0.65 EPS
www.americanbankingnews.com - May 4 at 11:13 PM |
Agilent Technologies (NYSE:A) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Agilent Technologies (NYSE:A) Income Statement, Balance Sheet and Cash Flow Statement
Agilent Technologies (NYSE A) Stock Chart for Saturday, May, 26, 2018
Loading chart…
